You are here

  • Home
  • Archive
  • Volume 20, Issue 4
  • Coronary artery bypass surgery continues to remain the treatment of choice for multivessel coronary artery disease even in the era of new-generation drug-eluting stents

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Coronary artery bypass surgery continues to remain the treatment of choice for multivessel coronary artery disease even in the era of new-generation drug-eluting stents

https://doi.org/10.1136/ebmed-2015-110211

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests FWM was one of the principal investigators for the SYNTAX trial.

    • Provenance and peer review Commissioned; internally peer reviewed.